TSX - HLS...Toronto Stock Exchange (TSX) - HLS Provided as part of an oral presentation and qualified by such, contains forward-looking statements, actual results may vary materially; HLS disclaims any duty to update HLS THERAPEUTICS INC ... TSX - HLS.
With respect toHLS's acquisition strategy, HLS management expects to compete principally with other pharmaceutical companies that seek to acquire late stage, mature and promotional stage pharmaceutical products as part of their growth strategy.
MCHP) has added an HLS design workflow ... (API) that executes hardware instructions concurrently and simplifies the expression of complex hardware parallelism as compared to other HLS offerings.
TORONTO, March 5, 2026 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX... HLS in-licensed the exclusive rights to NILEMDO and NEXLIZET® (bempedoic acid and ezetimibe) for the Canadian market from Esperion Therapeutics Inc.
26, 2026 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX. HLS), announces that it will release financial results for the three and twelve months ended December 31, 2025, on Thursday, March 12, 2026 ... ABOUT HLS THERAPEUTICS INC.
With the TGE now live, $HLS becomes available to the public, enabling broader participation in the Helios ecosystem as the network developers. $HLS Now Live on Major Exchanges. At launch, $HLS is ...
Asian student enrollment remained consistent with recent HLS classes, with 126 students in the J.D ... HLS spokesperson Jeff Neal declined to comment on the demographic composition of the Class of 2028, ...